Zivo Bioscience Inc's ticker is ZIVO and the CUSIP is 98978N101. A total of 2 filers reported holding Zivo Bioscience Inc in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,000 | -16.7% | 80,000 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 80,000 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | 0.0% | 80,000 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | 0.0% | 80,000 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | +50.0% | 80,000 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 80,000 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -27.3% | 80,000 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | +10.0% | 80,000 | 0.0% | 0.00% | – |
| Q4 2018 | $10,000 | -23.1% | 80,000 | 0.0% | 0.00% | – |
| Q3 2018 | $13,000 | -7.1% | 80,000 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $14,000 | +75.0% | 80,000 | 0.0% | 0.00% | – |
| Q1 2018 | $8,000 | 0.0% | 80,000 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +14.3% | 80,000 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | +40.0% | 80,000 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | -28.6% | 80,000 | 0.0% | 0.00% | – |
| Q1 2017 | $7,000 | -12.5% | 80,000 | 0.0% | 0.00% | – |
| Q4 2016 | $8,000 | +100.0% | 80,000 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -20.0% | 80,000 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | -16.7% | 80,000 | 0.0% | 0.00% | – |
| Q1 2016 | $6,000 | +20.0% | 80,000 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -16.7% | 80,000 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | -40.0% | 80,000 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $10,000 | – | 80,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CoreCap Advisors, LLC | 26,166 | $65,415 | 0.01% |
| Column Capital Advisors, LLC | 12,000 | $30,000 | 0.01% |